In another milestone for the Alchemist Group of Hospitals,
the Cardiac Team at Ojas Hospital Panchkula, a unit of Alchemist Hospitals
Ltd., achieved the first successful Evolut Fx Transcatheter Aortic Valve
Replacement (TAVR) in upper North India. The procedure was skillfully performed
by Dr. Rajat Datta, Director of the Department of Cardiology, along with Dr.
Anurag Sharma, Chairman of the Department of Cardiology, and Dr. Munish Dev,
Consultant in Cardiology at Ojas Hospital, Panchkula, a unit of Alchemist
Hospitals Ltd.
This groundbreaking procedure demonstrated excellent
deliverability, stability, and coaxial deployment. TAVR is a minimally invasive
technique designed to replace a narrowed aortic valve without the need for
open-heart surgery. The catheter-based approach enhances the procedure's less
invasive nature. This method is particularly beneficial for addressing aortic
stenosis, a condition where the heart's aortic valve fails to open properly.
Individuals facing aortic stenosis are encouraged to engage
in a comprehensive discussion with healthcare professionals to receive personalized
advice tailored to their specific situation.
This new generation of TAVR valve, as a result of advanced
R&D has excellent deliverability,
stability, coaxial deployment and allows easy coronary access for any coronary
procedure in future. All these features translate into a faster procedure,
easier deployment in tortuous or horizontal anatomy, good hemodynamics, longer
valve life and ease for the patient. Given our vast experience in performing
TAVRs, we are now able to deliver even better results for a healthier life for
our patients. The Alchemist group of hospitals remains at the forefront of
medical advancements, exemplifying a commitment to excellence in healthcare.
No comments:
Post a Comment